Cypherpunk’s $46M Zcash Markup Turns a $4.7M Operating Loss Into $39.4M of Net Income
Cypherpunk Technologies reported a net income of $39.4 million for the second quarter, largely due to a $46 million unrealized gain from its Zcash holdings. Excluding this accounting entry, the company incurred an operating loss of $4.7 million. The company's biotechnology subsidiary, Leap Therapeutics, is also seeking resources for its sirexatamab drug program.
- Entities
- Topic: Biotechnology
- Topic: Financial Reporting
- Company: Cypherpunk Technologies
- Topic: Cryptocurrency
- Game: Zcash
- Company: Leap Therapeutics
This article was reported and published by egamers.io. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.